Evaluation and management of transient ischemic attack and minor cerebral infarction

Mayo Clinic Proceedings

Volumn 79, Issue 8, 2004, Pages 1071-1086

  Flemming, Kelly D ^a   Brown Jr , Robert D ^a   Petty, George W ^a   Huston III, John ^a   Kallmes, David F ^a   Piepgras, David G ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CYANOCOBALAMIN; FOLIC ACID; GADOLINIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRIDOXINE; WARFARIN;

ANGIOGRAPHY; BLOOD CELL COUNT; BLOOD CLOTTING DISORDER; BRAIN INFARCTION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DRUG SAFETY; ELECTROCARDIOGRAPHY; EMBOLISM; HEART ATRIUM FIBRILLATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTERNAL CAROTID ARTERY OCCLUSION; NUCLEAR MAGNETIC RESONANCE IMAGING; RISK FACTOR; SECONDARY PREVENTION; SMOKING; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK;

EID: 3543051246     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/79.8.1071     Document Type: Conference Paper

References (55)

1. Culebras A, Kase CS, Masdeu JC, et al. Practice guidelines for the use of imaging in transient ischemic attacks and acute stroke: a report of the Stroke Council, American Heart Association. Stroke. 1997;28:1480-1497.
2. Furlan A, Higashida R, Wechsler L, et al, PROACT Investigators. Intraarterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial. JAMA. 1999;282:2003-2011.
3. Libman RB, Wirkowski E, Alvir J, Rao TH. Conditions that mimic stroke in the emergency department: implications for acute stroke trials. Arch Neurol. 1995;52:1119-1122.
4. Kidwell CS, Alger JR, Di Salle F, et al. Diffusion MRI in patients with transient ischemic attacks. Stroke. 1999;30:1174-1180.
5. Schaefer PW. Applications of DWI in clinical neurology. J Neurol Sci. 2001;186(suppl 1):S25-S35.
6. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke. 1999;30:2513-2516.
7. Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction: the Northern Manhattan Stroke Study. Stroke. 1995;26:14-20.
8. Agmon Y, Khandheria BK, Gentile F, Seward JB. Clinical and echocardiographic characteristics of patients with left atrial thrombus and sinus rhythm: experience in 20 643 consecutive transesophageal echocardiographic examinations. Circulation. 2002;105:27-31.
9. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol. 2001;38:1231-1266.
10. Meissner I, Whisnant JP, Khandheria BK, et al. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Mayo Clin Proc. 1999;74:862-869.
11. Mas JL, Arquizan C, Lamy C, et al, Patent Foramen Ovale and Atrial Septal Aneurysm Study Group. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001;345:1740-1746.
12. Peterson GE, Brickner ME, Reimold SC. Transesophageal echocardiography: clinical indications and applications. Circulation. 2003;107:2398-2402.
13. Warner MF, Momah KI. Routine transesophageal echocardiography for cerebral ischemia: is it really necessary? Arch Intern Med. 1996;156:1719-1723.
14. McNamara RL, Lima JA, Whelton PK, Powe NR. Echocardiographic identification of cardiovascular sources of emboli to guide clinical management of stroke: a cost-effective analysis. Ann Intern Med. 1997;127:775-787.
15. Kapral MK, Silver FL, Canadian Task Force on Preventive Health Care. Preventive health care, 1999 update, 2: echocardiography for the detection of a cardiac source of embolus in patients with stroke. CMAJ. 1999;161:989-996.
16. Stein PD, Alpert JS, Dalen JE, Horstkotte D, Turpie AG. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest. 1998;114(5, suppl):602S-610S.
17. Di Tullio MR, Homma S. Mechanisms of cardioembolic stroke. Curr Cardiol Rep. 2002;4:141-148.
18. Proceedings of the American College of Chest Physicians 5th Consensus on Antithrombotic Therapy: 1998. Chest. 1998;114(5, suppl):439S-769S.
19. Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group. Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial. infarction. Lancet. 1994;343:499-503.
20. van Es RF, Jonker JJC, Verheugt FWA, Deckers JW, Grobbee DE, Antithrombotics in the Secondary Prevention of Events in Coronary Thrombosis-2 (ASPECT-2) Research Group. Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial. Lancet. 2002; 360:109-113.
21. Salem DN, Levine HJ, Pauker SG, Eckman MH, Daudelin DH. Antithrombotic therapy in valvular heart disease. Chest. 1998;114(5, suppl): 590S-601S.
22. Hung J, Landzberg MJ, Jenkins KJ, et al. Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol. 2000;35: 1311-1316.
23. Bogousslavsky J, Regli F. Ischemic stroke in adults younger than 30 years of age: cause and prognosis [published correction appears in Arch Neurol. 1987;44:817]. Arch Neurol. 1987;44:479-482.
24. Bogousslavsky J, Regli F. Ischemic stroke in adults younger than 30 years of age: cause and prognosis [published correction appears in Arch Neurol. 1987;44:817]. Arch Neurol. 1987;44:479-482.
25. Amarenco P, Cohen A, Tzourio C, et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med. 1994;331:1474-1479.
26. Huston J III, James EM, Brown RD Jr, et al. Redefined duplex ultrasonographic criteria for diagnosis of carotid artery stenosis. Mayo Clin Proc. 2000;75:1133-1140.
27. Landwehr P, Schulte O, Voshage G. Ultrasound examination of carotid and vertebral arteries. Eur Radiol. 2001;11:1521-1534.
28. Nederkoorn PJ, van der Graaf Y, Hunink MG. Duplex ultrasound and magnetic resonance angiography compared with digital subtraction angiography in carotid artery stenosis: a systematic review. Stroke. 2003;34:1324-1332.
29. Kirsch JD, Wagner LR, James EM, et al. Carotid artery occlusion: positive predictive value of duplex sonography compared with arteriography. J Vase Surg. 1994;19:642-649.
30. El-Saden SM, Grant EG, Hathout GM, Zimmerman PT, Cohen SN, Baker JD. Imaging of the internal carotid artery: the dilemma of total versus near total occlusion. Radiology. 2001;221:301-308.
31. Patel SG, Collie DA, Wardlaw JM, et al. Outcome, observer reliability, and patient preferences if CTA, MRA, or Doppler ultrasound were used, individually or together, instead of digital subtraction angiography before carotid endarterectomy. J Neurol Neurosurg Psychiatry. 2002;73:21-28.
32. Goddard AJ, Mendelow AD, Birchall D. Computed tomography angiography in the investigation of carotid stenosis. Clin Radiol. 2001;56:523-534.
33. Huston J III, Fain SB, Riederer SJ, Wilman AH, Bernstein MA, Busse RF. Carotid arteries: maximizing arterial to venous contrast in fluoroscopically triggered contrast-enhanced MR angiography with elliptic centric view ordering. Radiology. 1999;211:265-273.
34. Huston J III, Fain SB, Wald JT, et al. Carotid artery: elliptic centric contrast-enhanced MR angiography compared with conventional angiography. Radiology. 2001;218:138-143.
35. Krinsky G, Maya M, Rofsky N, et al. Gadolinium-enhanced 3D MRA of the aortic arch vessels in the detection of atherosclerotic cerebrovascular occlusive disease. J Comput Assist Tomogr. 1998;22:167-178.
36. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445-453.
37. Barnett HJ, Taylor DW, Eliasziw M, et al, North American Symptomatic Carotid Endarterectomy Trial Collaborators. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med. 1998; 339:1415-1425.
38. CAVATAS Investigators. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet. 2001;357:1729-1737.
39. Yadav JS, SAPPHIRE Investigators. Stenting and angioplasty with protection in patients at high risk for endarterectomy: the SAPPHIRE Study [abstract]. Presented at: American Heart Association Meeting; Chicago, Ill; November 17-20, 2002.
40. Crouse JR III, Byington RP, Bond MG, et al. Pravastatin, lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II) [published correction appears in Am J Cardiol. 1995;75:862]. Am J Cardiol. 1995;75:455-459.
41. Crouse JR III, Byington RP, Bond MG, et al. Pravastatin, lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II) [published correction appears in Am J Cardiol. 1995;75:862]. Am J Cardiol. 1995;75:455-459.
42. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7-22.
43. Schievink WI. Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med. 2001;344:898-906.
44. EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: results of an international randomized trial. N Engl J Med. 1985;313:1191-1200.
45. Grubb RL Jr, Derdeyn CP, Fritsch SM, et al. Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA. 1998;280:1055-1060.
46. Ferrari E, Vidal R, Chevallier T, Baudouy M. Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis: benefit of oral anticoagulants. J Am Coll Cardiol. 1999;33:1317-1322.
47. Mohr JP, Thompson JL, Lazar RM, et al, Warfarin-Aspirin Recurrent Stroke Study Group. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med. 2001;345:1444-1451.
48. Felberg RA, Christou I, Demchuk AM, Malkoff M, Alexandrov AV. Screening for intracranial stenosis with transcranial Doppler: the accuracy of mean flow velocity thresholds. J Neuroimaging. 2002;12:9-14.
49. Demchuk AM, Christou I, Wein TH, et al. Accuracy and criteria for localizing arterial occlusion with transcranial Doppler. J Neuroimaging. 2000; 10:1-12.
50. Skutta B, Furst G, Eilers J, Ferbert A, Kuhn FP. Intracranial steno-occlusive disease: double-detector helical CT angiography versus digital subtraction angiography. AJNR Am J Neuroradiol. 1999;20:791-799.
51. Korogi Y, Takahashi M, Mabuchi N, et al. Intracranial vascular stenosis and occlusion: diagnostic accuracy of three-dimensional, Fourier transform, time-of-flight MR angiography. Radiology. 1994;193:187-193.
52. Oelerich M, Lentschig MG, Zunker P, Reimer P, Rummeny EJ, Schuierer G. Intracranial vascular stenosis and occlusion: comparison of 3D time of flight and 3D phase contrast MR angiography. Neuroradiology. 1998;40:567-573.
53. Chimowitz MI, Kokkinos J, Strong J, et al. The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology. 1995;45:1488-1493.
54. Gan R, Sacco RL, Kargman DE, Roberts JK, Boden-Albala B, Gu Q. Testing the validity of the lacunar hypothesis: the Northern Manhattan Stroke Study experience. Neurology. 1997;48:1204-1211.
55. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339:5-11.